Blog
  by

In the News: January 19-25

Sg2 is dedicated to helping our clients interpret the latest news and trends in health care. Below you’ll find our analysis of this week’s key industry headlines, along with links to related Sg2 resources.

ACC Releases Revised Anticoagulant Use Guidelines for Atrial Fibrillation Patients

The American College of Cardiology (ACC) has published revised guidelines for patients with atrial fibrillation who use anticoagulants during procedures from everything from dental visits to major surgery. The ACC will release an app in February to help clinicians determine when and if coagulation therapy should be stopped before a medical procedure.

As the incidence of atrial fibrillation grows, Sg2 projects both IP and OP cases of dysrhythmia will increase and there will be an expanding population treated with long-term anticoagulation therapy. These guidelines and the resulting app will be useful as leaders in CV think about crafting their atrial fibrillation strategy.


As Expected, White House Issues Memorandum to Freeze Pending Regulations

Within hours of President Trump’s inauguration, Chief of Staff Reince Priebus issued a memorandum to the heads of executive departments and agencies to halt or withdraw the submission of new or unpublished regulations (eg, the new Medicare ACO Track 1+ Model) until Trump’s appointees and designees have the opportunity to review them. Additionally, published rules (eg, the recently finalized mandatory bundled payment models) that have not taken effect may have their effective dates extended by 60 days and could be reopened for further notice-and-comment rulemaking.

While the memorandum is a typical action taken by incoming administrations, including President Obama in 2009, it is an important milestone in the flurry of regulatory and legislative activity anticipated in the coming months. For health care leaders, it will be important to ensure this policy noise does not paralyze planning processes. Read this recent Sg2 Consulting Spotlight to learn how environmental scenario planning can guide the development of hard-hitting plans without knowing exactly what the future will entail.


CDC: Rate of Kidney Failure From Diabetes Decreases by 54% Among Native Americans

A recent CDC Vital Signs report found that the rate of diabetes-related kidney failure decreased 54% among Native American adults between 1996 and 2013, from 58 per 100,000 to 27 per 100,000. In 1996, Native Americans had the highest rate of diabetes-related kidney failure compared to other races and ethnicities. By 2013, the population’s rate of diabetes-related kidney failure was lower than rates for African Americans and Hispanics, and was approaching the rates for Asians and whites.

This marked decline was attributed to team-based and population approaches employed by the Indian Health Service to improve care for Native Americans with diabetes. Given that fully half of US adults have at least 1 chronic disease, it is time to develop a comprehensive, strategic approach to chronic care. Read this recent Sg2 Letter to learn why the business case has never been stronger.

  • Share
  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Facebook Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube